2018 annual financial data
Fate Therapeutics 2018 Operating margin
Direct answer
Operating margin was -1,415.44%.
Operating income was -67,092,000 USD and net income was -66,598,000 USD.
Operating cash flow was -38,650,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,740,000 USD
- Operating income
- -67,092,000 USD
- Net income
- -66,598,000 USD
- Operating cash flow
- -38,650,000 USD